LVS-19377-36062
3 vaccinations
4 coded responses
14 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 972 / OR
- Registered
- 2021-05-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-16
Dose 1 — Pfizer-BioNTech
-
2021-05-08
Dose 2 — Pfizer-BioNTech
-
2021-05-10
Registered in v-safe
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-13
- 2021-05-14
- 2021-05-15
- 2021-05-22
-
2021-06-07
Survey response — day 28, dose 2MedDRA: Unevaluable event — Feeling: Good · Be unable to do your normal daily activitiesFree text: Donated blood & was very weak the next day.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-14
- 2021-06-20
-
2021-08-07
Survey response — 3 months, dose 2MedDRA: Bronchitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend schoolFree text: Bronchitis. Rapid test for COVID-19 was negative.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-08
Survey response — 6 months, dose 2MedDRA: Bronchitis, Menstruation irregular, Nasopharyngitis, Oligomenorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Different (longer, sometimes more frequent) menstrual cycles. Bronchitis and a cold virus (unrelated, contracted from known contacts).MedDRA releases: 2024-11 · check-in free text available
-
2021-12-17
Dose 3 — Moderna
- 2022-06-17
-
2022-12-17
Survey response — 12 months, dose 3MedDRA: Viral infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Unrelated viruses.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-17
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-20
- 2022-12-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-16 | Pfizer-BioNTech | |
| 2 | 2021-05-08 | Pfizer-BioNTech | |
| 3 | 2021-12-17 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — day 28, dose 2
Symptoms: Donated blood & was very weak the next day.
Release 9 — 3 months, dose 2
Symptoms: Bronchitis. Rapid test for COVID-19 was negative.
Release 10 — 6 months, dose 2
Symptoms: Different (longer, sometimes more frequent) menstrual cycles. Bronchitis and a cold virus (unrelated, contracted from known contacts).
Release 12 — 12 months, dose 3
Symptoms: Unrelated viruses.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | ✓ | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oligomenorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | · | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release